JOHNS HOPKINS INSTITUTE FOR NANOBIOTECHNOLOGY: INNOVATIVE DEVICE MAY HOLD THE KEY TO UNLOCKING THE POTENTIAL OF MRNA THERAPEUTICS
August 22, 2023
August 22, 2023
BALTIMORE, Maryland, Aug. 22 (TNSres) -- Johns Hopkins Institute for NanoBioTechnology issued the following news:
By John Moseman
While many only recognize mRNA as the crucial component in COVID-19 vaccines that have helped protect more than 230 million people around the world from contracting or developing severe disease since the pandemic began, messenger RNA therapeutics have the potential to treat various infectious diseases, autoimmune conditions, genetic disorders . . .
By John Moseman
While many only recognize mRNA as the crucial component in COVID-19 vaccines that have helped protect more than 230 million people around the world from contracting or developing severe disease since the pandemic began, messenger RNA therapeutics have the potential to treat various infectious diseases, autoimmune conditions, genetic disorders . . .